Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Linhares, José Juvenal ^a,b   Azevedo, Marcos ^b   Siufi, Adalberto Abraão ^b   de Carvalho, Cristina Valleta ^b,c   Wolgien, Maria Del Carmen Garcia Molina ^b   Noronha, Emmanuelle Coelho ^b   Bonetti, Tatiana Carvalho de Souza ^b,d   da Silva, Ismael Dale Cotrim Guerreiro ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c ABC Univ Fund Santo André   (Brazil)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Breast; Cancer; MicroRNAs; Polymorphisms

Indexed keywords

MICRORNA; MICRORNA 196A2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BRAZIL; BREAST CANCER; CANCER GRADING; CONTROLLED STUDY; FEMALE; FISHERMAN; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84873288267     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-119     Document Type: Article

References (20)

1. Verghese ET, Hanby AM, Speirs V, Hughes TA. Small is beautiful: microRNAs and breast cancer - where are we now?. J Pathol 2008, 215:214-221. 10.1002/path.2359, 18446835.
2. Zhang L, Yang N, Coukos G. MicroRNA in human cancer: one step forward in diagnosis and treatment. Adv Exp Med Biol 2008, 622:69-78. 10.1007/978-0-387-68969-2_6, 18546619.
3. Lorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070. 10.1158/0008-5472.CAN-05-1783, 16103053.
4. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Kerin MJ. MicroRNAs as novel biomarkers for breast cancer. J Oncol 2009, 2010:1-7.
5. Heneghan HM, Miller M, Kerin MJ. Circulating microRNAs: promising breast cancer biomarkers. Breast Cancer Res 2011, 13:402. 3109560, 21345257.
6. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
7. Ma L, Teruya-Feldstein J, Weinberg RA. Tumor invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688. 10.1038/nature06174, 17898713.
8. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, Cole CN. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007, 67:11612-11620. 10.1158/0008-5472.CAN-07-5019, 18089790.
9. McCafferty MPJ, McNeill RE, Miller N, Kerin MJ. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. Breast Cancer Res Treat 2009, 116:425-432. 10.1007/s10549-009-0429-7, 19507020.
10. Lee YM, Lee JY, Ho CC, Hong QS, Yu SL, Tzeng CR, Yang PC, Chen HW. MicroRNA 34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Breast Cancer Res 2011, 13:116.
11. Xu J, Hu Z, Xu ZF, Gu H, Yi L, Cao H, Chen J, Tian T, Liang J, Lin Y, Qiu W, Ma H, Shen H, Chen Y. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 2009, 30(8):1231-1236. 10.1002/humu.21044, 19514064.
12. Boucherat O, Guillou F, Aubin J, Jeannotte L. Hoxa5: a master gene with multifaceted roles. Med Sci (Paris) 2009, 25(1):77-82.
13. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S. Compromised HOXA5 function can limit p53 expression in human breast tumors. Nature 2000, 405:974-978. 10.1038/35016125, 10879542.
14. Xu W, Xu J, Liu S, Chen B, Wang X, Li Y, Qian Y, Zhao W, Wu J. Effects of common polymorphism rs11614913 in miR-196a2 and rs2910164 on cancer susceptibility: a meta-analysis. PLoS One 2011, 6(5):e20471. 10.1371/journal.pone.0020471, 3102728, 21637771.
15. Hu Z, Liang J, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H. Common genetic variants in Pre-MicroRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009, 30(1):79-84. 10.1002/humu.20837, 18634034.
16. Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P, Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P, Burwinkel B, Peterlongo P. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 2010, 31(1):1052-1057.
17. Catucci I, Verderio P, Pizzamiglio S, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Ripamonti CB, Pasini B, Barile M, Viel A, Giannini G, Papi L, Varesco L, Martayan A, Riboni M, Volorio S, Radice P, Peterlongo P. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Breast Cancer Res Treat 2011, 125(3):855-860. 10.1007/s10549-010-1068-8, 20652397.
18. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y. MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 2009, 69:5970-5977. 10.1158/0008-5472.CAN-09-0236, 2716085, 19567675.
19. Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 2011, 125(2):571-574. 10.1007/s10549-010-0993-x, 20640596.
20. Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, Liu ZH, Peng JY, Zhou YK, Qin HL. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep 2012, 39(1):269-275. 10.1007/s11033-011-0735-0, 21625865.